- Home
- OWL vs SNN Comparison
OWL vs SNN Comparison
Compare OWL & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OWL
- SNN
- Stock Information
- Founded
- OWL 2020
- SNN 1856
- Country
- OWL United States
- SNN United Kingdom
- Employees
- OWL N/A
- SNN N/A
- Industry
- OWL Investment Managers
- SNN Industrial Specialties
- Sector
- OWL Finance
- SNN Health Care
- Exchange
- OWL Nasdaq
- SNN Nasdaq
- Market Cap
- OWL 10.6B
- SNN 15.2B
- IPO Year
- OWL N/A
- SNN 1999
- Fundamental
- Price
- OWL $15.35
- SNN $33.22
- Analyst Decision
- OWL Buy
- SNN Hold
- Analyst Count
- OWL 15
- SNN 4
- Target Price
- OWL $22.50
- SNN $33.50
- AVG Volume (30 Days)
- OWL 14.7M
- SNN 669.8K
- Earning Date
- OWL 10-30-2025
- SNN 10-30-2025
- Dividend Yield
- OWL 5.83%
- SNN 2.21%
- EPS Growth
- OWL 47.85
- SNN 59.91
- EPS
- OWL 0.08
- SNN 0.56
- Revenue
- OWL $2,745,943,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- OWL $17.06
- SNN $7.85
- Revenue Next Year
- OWL $21.21
- SNN $5.43
- P/E Ratio
- OWL $199.00
- SNN $28.79
- Revenue Growth
- OWL 27.24
- SNN 5.35
- 52 Week Low
- OWL $14.54
- SNN $23.69
- 52 Week High
- OWL $26.73
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- OWL 40.65
- SNN 33.56
- Support Level
- OWL $15.37
- SNN $31.83
- Resistance Level
- OWL $16.34
- SNN $37.06
- Average True Range (ATR)
- OWL 0.69
- SNN 0.54
- MACD
- OWL -0.08
- SNN -0.33
- Stochastic Oscillator
- OWL 31.47
- SNN 24.43
About OWL Blue Owl Capital Inc.
Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.